Navigation Links
Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
Date:10/6/2008

Vice President and Chief Medical Officer at Ironwood.

"These novel findings provide valuable insight into the possible role of cGMP in alleviating intestinal pain and may explain the reduction in intestinal pain observed in patients with IBS-C treated with linaclotide in our Phase 2b studies," said Mark Currie, Ph.D., Senior Vice President, R&D and Chief Scientific Officer at Ironwood.

About Linaclotide

Linaclotide is a first-in-class compound currently being evaluated for the treatment of IBS-C, chronic constipation (CC), and other gastrointestinal disorders. Linaclotide was designed to exert its effect on the intestine with minimal systemic exposure. Linaclotide is an agonist of guanylate cyclase type-C, a receptor found on the lining of the intestine. Linaclotide demonstrated proof of concept in a comprehensive Phase 2b program, comprised of two clinical studies in over 700 patients with either IBS-C or CC. In patients with IBS-C, linaclotide reduced abdominal pain and relieved constipation-the hallmarks of the condition-throughout the 12-week treatment period. In patients with CC, linaclotide reduced constipation throughout the 4-week study period. Linaclotide was well tolerated at all doses in both Phase 2b studies, with the most common adverse event being diarrhea. A United States patent covering linaclotide composition of matter expires in 2025. In September 2007, Ironwood and Forest Laboratories entered into a 50/50 collaboration to co-develop and co-promote linaclotide in the United States. Ironwood retains exclusive rights to linaclotide outside of North America.

About Irritable Bowel Syndrome (IBS)

One out of six adults in developed countries suffers from IBS, a chronic condition marked by abdominal pain and disturbed bowel function. IBS accounts for 12% of adult visits to primary care physicians and is the most common disorder diagnosed by gastroenterologists. Healthcare costs associated with IBS exceed $25 billion ann
'/>"/>

SOURCE Ironwood Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
3. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
4. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
5. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate ... stock in an at-the-market registered direct offering, led ... The Company entered into definitive purchase agreements with ... to sell an aggregate of 3,603,603 shares of ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, ... and technologies must be able to protect ... (IP). (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ... nature of the Medical Device Industry, it ... industry sectors of cases involving IP infringement. ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence ... a Medical Fitness Center by the Medical Fitness ... and fitness centers to achieve their full potential. ... only certified fitness center in the western suburbs ... "The certification means the Cadence Fitness & Health ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... 16 Reportlinker.com announces that a ... in its catalogue. , ... Market Outlook To 2014: Policy environment, ... , http://www.reportlinker.com/p0155347/Reportlinker-Adds-The-Middle-Eastern-Pharmaceutical-Market-Outlook-To-2014-Policy-environment-market-structure-competitive-landscape-growth-opportunities.html ...
... Oct. 16 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) ... meeting at 1:30 p.m. eastern time on Oct. 19, 2009. ... the management presentation which will follow. During that presentation, management ... , The webcast can be accessed via a link on ...
Cached Medicine Technology:Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 3Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 4Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 5Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 6Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 7Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 8Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 9Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 10Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 11
(Date:4/13/2014)... A low-cost empowerment program for adolescent girls ... harassment of these girls, who live in an ... frequently attacked, a large new study shows. , ... School of Medicine, Lucile Packard Children,s Hospital Stanford ... validated the program,s effectiveness in combating an appallingly ...
(Date:4/11/2014)... Fresh insights into the processes that control brain cell ... cancer and other brain-related disorders. , Scientists have gained ... molecule that controls how and when nerve and brain ... brain to develop and keeps it healthy. Their findings ... out of control, which is a fundamental characteristic of ...
(Date:4/11/2014)... is still open for the fifteenth annual European League ... 14 June 2014 in Paris, France. , A large ... members of the press, the majority of which are ... des Congrs de Paris. Hotel reservations are made on ... room today to avoid disappointment! , Press registration is ...
(Date:4/11/2014)... MAYWOOD, Il. (April 11, 2014) A Loyola University ... a link between overuse injury rates in young athletes ... injuries in athletes who come from families that can ... rate in lower-income athletes who are on public insurance ... privately insured young athletes are twice as likely as ...
(Date:4/9/2014)... paracetamol toxicity is the most common cause of ALF ... 150 to 200 deaths and 15 to 20 LTs occur ... Wales. LT is the definitive treatment for ALF patients ... of selection for LT (the King,s College Criteria) are not ... time or quantify the mortality risk for individual patients. ...
Breaking Medicine News(10 mins):Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4Health News:Young athletes from higher income families more likely to suffer serious overuse injuries 2Health News:Young athletes from higher income families more likely to suffer serious overuse injuries 3Health News:New prediction model to improve patient survival after paracetamol-related liver failure 2
... advocacy organization in the State of Pennsylvania, is ... the House Dennis M. O,Brien in,their denouncement of ... for vote today. The bill requires insurance companies ... individuals less than 21 years,old, but was gutted ...
... and random environmental factors, according to findings from ... in the scientific journal Archives of Sexual ... Biological and Chemical Sciences, and Karolinska Institutet in ... are specific to an individual, and may include ...
... for anybody who cares about Lung Cancer, the Number One Cancer Killer ... Lung Cancer. For the first time, in the last four decades, Lung ... and the tireless work over the last five years of Laurie Fenton, ... ...
... process does not provide our veterans with the services ... those who so dutifully served us., JAMAICA, N.Y., ... W. Meeks (D-NY) of the Sixth Congressional,District, announced that ... to suspend the Capital Asset Realignment for Enhanced Services,(CARES) ...
... how to be footloose and injury-free , , SATURDAY, June ... simple pleasures of summer, but some who doff their shoes ... In some cases, those injuries develop infections that require surgery. ... tips from the American College of Foot and Ankle Surgeons: ...
... Incontinence and Personal Care product line by Birchwood ... mild anal incontinence and for everyday personal care. ... rectal, vaginal, and perineal cleanliness while relieving irritation ... help decrease anxiety while improving quality of life ...
Cached Medicine News:Health News:AutismLink, Autism Center of Pittsburgh Denounce Senate Autism Bill 2Health News:Homosexual behavior due to genetics and environmental factors 2Health News:Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter 2Health News:Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter 3Health News:Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter 4Health News:Congressman Gregory W. Meeks to Ask for Suspension of CARES Process at the St. Albans Veteran Campus 2Health News:Barefoot Lifestyle Has Its Dangers 2Health News:Birchwood Laboratories Expands B-SURE™ Incontinence and Personal Care Product Line™; Three New Products Added Including B-SURE Fresh 'n Go™, B-SURE Bottom Balm™ and B-SURE Traveler™ 2
... Shoulder Instrument Systems offer the ... and mini-open shoulder repairs, such ... repair. Smith & Nephew shoulder ... facilitate an easier and more ...
Suture Cutter, straight...
Suture Cutter, 15 Up Curve...
Suture scissor...
Medicine Products: